Ma D Y, Dong Y, Feng H, Wang T T, Zhao J
Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.
Department of Pathology, Peking University First Hospital, Beijing 100034, China.
Zhonghua Bing Li Xue Za Zhi. 2020 Aug 8;49(8):806-811. doi: 10.3760/cma.j.cn112151-20200106-00013.
To investigate the possible influencing factors of false-negative diagnosis of cervical/vaginal liquid based cytology, and further improve the sensitivity of cervical/vaginal cytology. The results of cervical/vaginal cytology of outpatients and inpatients in Department of Obstetrics and Gynecology, Peking University First Hospital from July 2015 to December 2018 were analyzed retrospectively. Cytological false-negative cases were defined as the patients whose cytological results showed no intraepithelial neoplasia and malignant (NILM), but whose biopsy was diagnosed as cervical intraepithelial neoplasia (CIN) 2 or vaginal intraepithelial neoplasia (VAIN) 2 or above within 6 months of the diagnosis. The review of false-negative cytology smear was completed by two senior cytologists. Two-class logistic regression was used to evaluate the influence of age, location or number of lesion, and degree of lesion on the false-negative diagnosis of cytology. The reasons for the inconsistency of false-negative diagnosis were analyzed with the review results. Among 1 009 cases of CIN2+ and VAIN2+ lesions, 180 cases (17.8%) showed NILM. After reviewing the smear, 123 cases (68.3%) were identified as NILM and 57 cases(31.7%) as abnormal. The false-negative rate was the highest (20.8%) in the patients with age≤30 years, and the risk was 8.85 times higher than the patients aged 31 to 60 years (0.001), 9.26 times than the patients aged≥60 years (0.001). The highest cytological false-negative rate was 50.0% for cervical polyps or intraductal lesions. The false-negative rate of vaginal wall or vaginal pedicle rupture was 13.0%; that of single cervical lesion was 22.3%; that of high-grade squamous intraepithelial lesion(HSIL) and adenocarcinoma in situ of cervix(AIS) was 13.7% and that of malignant lesions was 3.9%. The most common cell types in the reviewed abnormal cases were squamous cells in the middle surface layer (38.6%) and squamous cells in the outer bottom layer (24.6%). The abnormal cells in all smears was the most common distribution (59.7%), the number of abnormal cells in the smear was less than 10 (31.6%), nuclear enlargement and light staining were common (42.2%), and inflammatory lesions or keratotic changes in the background were most common (59.7%). Age of the patient, location or number of lesion, and degree of lesion are associated with false-negative diagnosis of cytology. Summarizing sampling experience and improving sampling skills will help reduce the occurrence of false-negative cases. Cytopathologists should examine slightly abnormal changes more carefully and learn how to further reduce the false-negative rate procactively.
为探讨宫颈/阴道液基细胞学假阴性诊断的可能影响因素,进一步提高宫颈/阴道细胞学的敏感性。回顾性分析北京大学第一医院妇产科2015年7月至2018年12月门诊及住院患者的宫颈/阴道细胞学检查结果。细胞学假阴性病例定义为细胞学结果显示无上皮内瘤变及恶性病变(NILM),但活检在诊断后6个月内被诊断为宫颈上皮内瘤变(CIN)2级或阴道上皮内瘤变(VAIN)2级及以上的患者。由两位资深细胞病理学家完成对假阴性细胞学涂片的复查。采用二分类逻辑回归评估年龄、病变部位或数量以及病变程度对细胞学假阴性诊断的影响。结合复查结果分析假阴性诊断不一致的原因。在1009例CIN2 +和VAIN2 +病变中,180例(17.8%)显示为NILM。复查涂片后,123例(68.3%)被确定为NILM,57例(31.7%)为异常。年龄≤30岁的患者假阴性率最高(20.8%),其风险比31至60岁的患者高8.85倍(P = 0.001),比≥60岁的患者高9.26倍(P = 0.001)。宫颈息肉或导管内病变的细胞学假阴性率最高,为50.0%。阴道壁或阴道蒂破裂的假阴性率为13.0%;单个宫颈病变的假阴性率为22.3%;高级别鳞状上皮内病变(HSIL)和宫颈原位腺癌(AIS)的假阴性率分别为13.7%和3.9%。复查异常病例中最常见的细胞类型是中层表层鳞状细胞(38.6%)和外底层鳞状细胞(24.6%)。所有涂片中异常细胞呈最常见分布(59.7%),涂片中异常细胞数量少于10个(31.6%),细胞核增大及淡染常见(42.2%),背景中炎症病变或角化改变最常见(59.7%)。患者年龄、病变部位或数量以及病变程度与细胞学假阴性诊断相关。总结取材经验并提高取材技巧有助于减少假阴性病例的发生。细胞病理学家应更仔细地检查轻微异常变化,并主动学习如何进一步降低假阴性率。